Article
A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
The journal of pathology. Clinical research - 1 Apr 2018
Xu Jing, Xu Li, Lau Yeh S, Gao Yandi, Moore Steven A, Han Renzhi
Abstract excerpt
Mutations in ANO5 cause several human diseases including gnathodiaphyseal dysplasia 1 (GDD1), limb-girdle muscular dystrophy 2L (LGMD2L), and Miyoshi myopathy 3 (MMD3). Previous work showed that complete genetic disruption of Ano5 in mice did not recapitulate human muscular dystrophy, while residual expression of mutant Ano5 in a gene trapped mouse developed muscular dystrophy with defective membrane repair. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
